Krankenhaus und Poliklinik Ruedersdorf GmbH

At Krankenhaus und Poliklinik Ruedersdorf GmbH, clinical research in these areas focuses on chronic inflammatory demyelinating polyneuropathy and inclusion body myositis. The studies are designed to assess whether new treatments can improve symptoms, slow disease activity, and offer better control of these complex conditions.

• Evaluating a new therapy for inclusion body myositis to understand its impact on function and safety
• Studying treatment effectiveness in chronic inflammatory demyelinating polyneuropathy with a focus on reducing relapse

This work reflects a specialized interest in neurology and pain therapy, with research aimed at improving care for patients living with rare immune-related and muscle disorders.

The site is conducting targeted trials for adults affected by inclusion body myositis and chronic inflammatory demyelinating polyneuropathy. These studies are intended to test whether new approaches can support disease control, improve daily physical abilities, and provide useful safety information for future treatment options.

• Testing a potential therapy for inclusion body myositis to measure functional benefit
• Assessing a treatment for chronic inflammatory demyelinating polyneuropathy to compare outcomes with placebo

With a small but focused research portfolio, the Rüdersdorf clinic contributes to clinical development in difficult-to-treat neuromuscular diseases and related immune-mediated conditions.